Wellington Management Group
AERI

Wellington Management Group’s Aerie Pharmaceuticals AERI Stock Holding History

Wellington Management Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$359K – 2330
2016
Q4 		$359K Hold
200
– – ﹤0.01% 2063
2016
Q3 		$373K Buy
+200
New +$4.41K ﹤0.01% 2039

Wellington Management Group's AERI Position: Q4 2022 in Review

Wellington Management Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 231,847 shares — an estimated $3.51M sold.

Wellington Management Group first reported a position in AERI in Q4 2013 and held it in 33 quarters. The position peaked at $360M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Wellington Management Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 231,847 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.51M.
  • Wellington Management Group first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 33 quarters.
  • Wellington Management Group's Aerie Pharmaceuticals position peaked at $360M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.